Filling the need for trusted information on national health issues…

Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Lessons Learned From Ebola Outbreak Demonstrate Importance Of Vaccine Research, Development

Center for Global Health Policy’s “Science Speaks”: Lessons from Ebola: A vaccine fast track too slow demonstrates need to prepare for pandemic potential diseases Elizabeth Bukowski, freelance journalist and veterinarian, reports from the 3rd International One Health Congress in Amsterdam and discusses comments from the director of the Jenner Institute…

Blog Post Discusses GHTC Report, Briefing On Role Of Global Health R&D In Preparedness

Global Health Technologies Coalition’s “Breakthroughs”: GHTC briefing highlights importance of global health innovation in protecting U.S. and world from threats like Ebola Kat Kelley, senior program assistant at GHTC, discusses the launch of GHTC’s sixth annual policy report titled, “Meeting the challenge, seizing the opportunity: U.S. leadership can advance global…

New Tool Shows Promise For Studying Relapse Of Malaria

Vaccine News Daily: New tool for studying relapsing malaria infections “A new tool could be instrumental in transforming the medical community’s search for novel treatments against relapsing malaria infections. Researchers at Seattle BioMed recently used a human-chimeric mouse model to further study Plasmodium vivax malaria parasite liver infections. The scientists…

Simplified Antibiotic Regimen Can Effectively Treat Sick Babies, Studies Show

News outlets report on results from two studies — one in The Lancet and another in The Lancet Global Health — that suggest that a simplified antibiotic regimen can effectively treat sick babies. HealthDay News/U.S. News & World Report: Simpler Antibiotic Regimen Helps Sick Babies in Developing Nations “Newborns and young…

Single-Dose Malaria Drug Performs Well In Laboratory Tests, Study Shows

The Hindu: Candidate malaria drug may cure with single dose “Last year, AstraZeneca, the global drug company, closed its research center in Bengaluru. One of the legacies of the work carried out there is the identification of a novel candidate drug for malaria. In laboratory tests, this molecule has shown…

Experimental Ebola Vaccine Trials Show Safety Of Drug, Ability To Trigger Immune Response

Media outlets report on results from two Ebola experimental drug trials published in the New England Journal of Medicine on Wednesday. The reports, titled “A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report” and “Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe — Preliminary Report”, suggest…

GHTC Provides Roundup Of Recent Global Health Research News

Global Health Technologies Coalition’s “Breakthroughs”: Research Roundup: clinical trials for experimental Ebola vaccines, genetic traits that affect malaria risk, and progress toward a hookworm vaccine Kat Kelley, senior program assistant at GHTC, highlights some of the past week’s news in global health research (3/30).

Malaria Test Identifies Asymptomatic Malaria Carriers, Study Says

SciDev.Net: Diagnostic tests plumb depths of ‘hidden malaria’ “A self-styled ‘ultrasensitive’ malaria test could lead to more accurate identification of the potentially significant pool of people who carry the disease without showing any symptoms, a paper has found. The paper indicates that these ‘asymptomatic carriers’ are far more common than…

USG Awards Pharmaceutical Company Funds To Develop Ebola Treatment

The Hill: Feds award company up to $35M to develop Ebola drug “The Department of Health and Human Services (HHS) on Tuesday awarded about $12 million to a North Carolina pharmaceutical company that has been developing Ebola treatments. The company, BioCryst Pharmaceuticals, has created a ‘promising’ experimental drug that prevents…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.